Report of the Diagnosis Working Group (2022)
Summary
This report presents the work of the International Lipoedema Association’s Diagnosis Working Group, established to examine how lipoedema, now referred to by ILA as lipalgia syndrome, can be clinically diagnosed based on the best available evidence. Using the PICO evaluation process, existing guidelines and literature alongside clinical expertise, the group reviewed established and proposed diagnostic criteria and developed a simplified diagnostic scheme.
The proposed scheme identifies three major diagnostic criteria: symmetrical disproportionate distribution of subcutaneous fatty tissue between the upper and lower body; enhanced sensitivity to touch with objective allodynia elicited through a pinch test; and normal hands and feet in the absence of obesity or lymphoedema complications. A “cuff sign” at the ankle, elbow or wrist is included as a minor supporting criterion. The report also explores areas requiring further research, including pain, obesity, oedema, disease progression, severity, quality of life and the terminology used to describe the syndrome.
Authors
Working Group members: Håkan Brorson, MD, PhD; Domenico Corda, MD; Francesco Greco, MD, PhD; Leif Perbeck, MD, PhD; Cristhian Pomata, MD; Anna Towers, MD; and Christian Ure, MD.
Published
International Lipoedema Association (ILA), 2022. Report of the Diagnosis Working Group.
Supported by
No external funding or industry support is stated in the report.
Lipoedema: a paradigm shift and consensus (2020)
Journal Reference
Summary
This publication presents the European consensus on lipoedema, offering a comprehensive review of current evidence and clinical practice. It explores key controversies surrounding the condition, challenges outdated concepts, and proposes a new framework for diagnosis, treatment and long-term management. The document highlights the importance of multidisciplinary care, weight management, psychological support and patient-centred treatment strategies to improve outcomes for people living with lipoedema.
Authors
Lead authors: Tobias Bertsch and Gabriele Erbacher (Földi Clinic, Hinterzarten, European Center of Lymphology, Germany)
Author: Rebecca Elwell (University Hospitals of North Midlands NHS Trust, UK)
Foreword: Hugo Partsch, Emeritus Professor of Dermatology, Medical University of Vienna, Austria.
Published in
Journal of Wound Care, Vol. 29, Supplement 2, No. 11, November 2020. Published by MA Healthcare Ltd, London, United Kingdom.
Supported by
The supplement was supported by JOBST and medi.
Obesity-related lymphoedema – underestimated and undertreated (2018)
Journal Reference
Summary
This publication examines the relationship between obesity and lymphoedema, highlighting obesity as an important and often underestimated contributor to the development and worsening of lymphatic disease. It reviews proposed pathophysiological mechanisms linking obesity and impaired lymphatic function and discusses the challenges of treating obesity-related lymphoedema.
The article advocates a long-term, multidisciplinary approach that addresses both lymphoedema and obesity, presenting the multimodal treatment concept used at the Földi Clinic, including complex decongestive therapy, psychological and medical care, exercise, nutritional counselling and, where appropriate, bariatric and plastic surgery. The publication also discusses lipoedema, particularly in relation to obesity and lymphoedema, and challenges the use of the term “lipolymphoedema.”
Authors
Author: Tobias Bertsch (Földi Clinic, Hinterzarten – European Centre for Lymphology, Germany).
Published
Phlebologie, Vol. 47, No. 2, pp. 75–83, 2018. DOI: 10.12687/phleb2410-2-2018. Published by Schattauer.
Supported by
No external funding or industry support is stated in the publication. The author declares no conflict of interest and acknowledges E. Földi for personal and professional support.